Observational studyClinical pharmacology and therapeutics2021

Exposure-Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non-Small Cell Lung Cancer Patients.

Stefanie L Groenland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.